#news #biotech GSK jilts Ionis rare disease drug as FDA filing nears

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK jilts Ionis rare disease drug as FDA filing nears .GlaxoSmithKline has jilted Ionis Pharmaceuticals just before the pair was due to file for approval of inotersen. The action furthers recently installed GSK CEO Emma Walmsley’s plan to purge the Big Pharma of its rare disease programs.

from FierceBiotech: Biotech http://ift.tt/2uvvnul